Comparison between guideline-preferred and nonpreferred first-line HIV antiretroviral therapy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  American Journal of Managed Care

• Publication date

  2014-06-19

• Fields of study

  Medicine

• Identifiers
  PMID 25180433
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens

  2012cited by this paper
• Antiretroviral Therapy Adherence, Medication Use, and Health Care Costs During 3 Years of a Community Pharmacy Medication Therapy Management Program for Medi-Cal Beneficiaries with HIV/AIDS

  2011cited by this paper
• Factors Associated with Complete Adherence to HIV Combination Antiretroviral Therapy

  2011cited by this paper
• A retrospective study of HIV antiretroviral treatment persistence in a commercially insured population in the United States

  2011cited by this paper
• What's the Risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression.

  2009cited by this paper
• Consistency of Initial Antiretroviral Therapy With HIV Treatment Guidelines in a US Cohort of HIV-Infected Women

  2008cited by this paper
• Estimation of HIV incidence in the United States.

  2008cited by this paper
• Practical and Conceptual Challenges in Measuring Antiretroviral Adherence

  2006cited by this paper
• Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors.

  2005cited by this paper
• HIV-1 Drug Resistance Evolution Among Patients on Potent Combination Antiretroviral Therapy With Detectable Viremia

  2005cited by this paper
• Comparing total health care costs and treatment patterns of HIV patients in a managed care setting

  2004cited by this paper
• Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy

  2004cited by this paper
• Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death

  2004cited by this paper
• Estimating log models: to transform or not to transform?

  2001cited by this paper
• Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy

  2001cited by this paper
• The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.

  1998cited by this paper

• Trends in Comorbid Conditions Among Medicaid Enrollees With HIV

  2019cites this paper
• Compliance with clinical guidelines and adherence to antiretroviral therapy among patients living with HIV

  2018influential citation
• Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting

  2016cites this paper
• Evaluation of Guideline-Recommended Combined Antiretroviral Treatment Regimens in Commercially-Insured Patients Living in the United States Between 2007 and 2009

  2016cites this paper
• Abbreviated Bibliography Since 1988 , healthcare researchers have used Truven Health MarketScan

  2012cites this paper